IP Expert’s Cheat Sheet on Non-Disclosure Agreements (NDAs) That Won’t Give You Headaches

Posted by Timi Olotu on August 3, 2017 at 4:00 PM

Jurgen Vollrath is the expert you want on your side when it comes to all things intellectual property. He was chief intellectual property (IP) officer at SAP and is president of Exponential Technology Counsel

Read More

Topics: IP & Innovation, IP Risk, Intellectual Property, Open Innovation

A holistic view of intellectual property and how to use it strategically

Posted by Hejab Azam on July 19, 2017 at 5:14 PM

I had the pleasure of interviewing Liz Ward, Principle of Virtuoso Legal, a boutique IP firm. If there’s any law firm that understands the holistic view and strategic use of intellectual property, it’s them. Although Virtuoso is a small boutique IP firm, they have outcompeted large magic circle firms by wining second place for ‘IP team of the year’ at The Lawyer Magazine Awards 2017.

Read More

Topics: IP & Innovation, IP Risk, Intellectual Property, IP Analysis

Feeding 10 billion: Food and intellectual property

Posted by Hejab Azam on April 10, 2017 at 7:00 AM

Last week, we discussed how a rising global population places strain on methods of food production and how technological advances could be used to feed 10 billion people

But that was only half the tale. Providing food security to so many people relies on technological innovations to solve problems at such a scale that IP conflicts occur regularly. Unfortunately, a system designed to protect and incentivise innovation can actually stifle development and even exacerbate issues.

In this article, we will look at the role IP plays in agriculture and how that impacts a stretching global food chain.

Read More

Topics: Intellectual Property, food

Lexmark v Impressions and resellers' rights

Posted by Hejab Azam on March 27, 2017 at 5:30 PM

The US Supreme Court is currently re-examining the patent exhaustion doctrine in Lexmark International v Impression Products. Impression resell Lexmark’s imported products back into the US. This was originally held by the Federal Circuit as an infringing act and not exhausting the patentee’s rights, therefore making Impressions liable for patent infringement.

Read More

Topics: Intellectual Property

What challenges does the patent industry face in 2017?

Posted by Joe Bamsey on December 5, 2016 at 3:51 PM

Gene Quinn and special guests look back at the most important moments of 2016, and consider the issues that will shape the patent industry in 2017.

Read More

Topics: IP & Innovation, Intellectual Property, Legal

Why software patents are worth the trouble

Posted by Joe Bamsey on November 3, 2016 at 9:30 AM

There is a prevailing view within much of the software industry that it is simply not worth the bother to patent. This view has been strengthened by landmark legal cases, which support the myth, most notably the case involving Alice Corporation versus CLS Bank International. This was widely regarded as a definitive outcome that appears to declare the software patent as null and void. However, ‘software’ companies continue to file patents. Why would they continue to do this if the Alice ruling suggests it’s irrational?

Read More

Topics: Patents, Software, Intellectual Property

What ™ and ® can do for your brand

Posted by Hejab Azam on November 2, 2016 at 10:15 AM

Intellectual property can be one of the most valuable assets to an organisation, and there are various ways to protect it. The most common ways are patents, copyright, or trademarks, and each of these different rights protect different aspects of a business.

Read More

Topics: Copyright, Intellectual Property, Trademarks

The most informative articles across R&D and IP—all in one newsletter

Academy by PatSnap—free video courses for R&D and IP innovators 

Join PatSnap's free Academy to learn how you can increase innovation ROI and foster a productive culture—from ideation to commercialisation.

Learn for Free

Pharmaceuticals guide on turning expiring patents into priceless opportunities

Do you know which patents in your specialist sector are due to expire? Do you know how they can help you outthink competitors? Reading this eBook ensures you do.


Download Now

How to solve declining R&D productivity and ROI—10 experts provide answers

Former president of R&D at Pfizer and 9 cross-industry experts diagnose the top R&D challenges—and how you can solve them.

Read Expert Guide

Get a full test run on the PatSnap platform—no cost, no strings

Wondering exactly how PatSnap would fit into and benefit your business? Request a demonstration, tailored to address your needs, from one of our tech experts.